149 results on '"Schut, Frederik T."'
Search Results
2. Translating innovative medical devices from prototype to practice: A Delphi study of urgent financial barriers and promising solutions
3. Preconditions for efficiency and affordability in competitive healthcare markets: Are they fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland? Ten years later
4. Financing COVID-19-related health care costs in the Dutch competitive health system during 2020 and 2021: Overall experiences and policy recommendations for improving health system resilience
5. The long and winding road towards payment for healthcare innovation with high societal value but limited commercial value: A comparative case study of devices and health information technologies
6. Financial risk allocation and provider incentives in hospital–insurer contracts in The Netherlands
7. Do health insurers use target marketing as a tool for risk selection? Evidence from the Netherlands
8. Strategic cost-shifting in long-term care. Evidence from the Netherlands
9. Does independent needs assessment limit use of publicly financed long-term care?
10. Who can see it coming? Demand‐side selection in long‐term care insurance related to decision‐making abilities.
11. Displaced, disliked and misunderstood: A systematic review of the reasons for low uptake of long-term care insurance and life annuities
12. Does price deregulation in a competitive hospital market damage quality?
13. Managed competition in the Netherlands: Do insurers have incentives to steer on quality?
14. The 2015 long-term care reform in the Netherlands: Getting the financial incentives right?
15. Who will become my co-residents? The role of attractiveness of institutional care in the changing demand for long-term care institutions
16. Aligning Ambition and Reality: A Multiple Case Study Into Synergistic Influences of Financial and Other Factors on the Outcomes of Integrated Care Projects.
17. Strategies to Counteract Risk Selection in Social Health Insurance Markets
18. Switching gains and health plan price elasticities: 20 years of managed competition reforms in The Netherlands
19. Consumer Price Sensitivity and Social Health Insurer Choice in Germany and the Netherlands
20. Competition policy for health care provision in the Netherlands
21. What health plans do people prefer? The trade-off between premium and provider choice
22. Switching health insurers: the role of price, quality and consumer information search
23. Changing roles of health insurers in France, Germany, and the Netherlands: any lessons to learn from Bismarckian systems?
24. Tackling hospital waiting times: The impact of past and current policies in the Netherlands
25. Spillover effects of supplementary on basic health insurance: evidence from the Netherlands
26. Do patients choose hospitals with high quality ratings? Empirical evidence from the market for angioplasty in the Netherlands
27. Assessing hospital competition when prices don't matter to patients: the use of time-elasticities
28. Which preferred providers are really preferred? Effectiveness of insurers' channeling incentives on pharmacy choice
29. Pricing behaviour of nonprofit insurers in a weakly competitive social health insurance market
30. Health care systems in transition: the Netherlands: Part I: Health care reforms in the Netherlands: miracle or mirage?
31. Preferences and choices for care and health insurance
32. Managed competition and consumer price sensitivity in social health insurance
33. Channeling Consumers to Preferred Providers and the Impact of Status Quo Bias: Does Type of Provider Matter?
34. Guaranteed Access to Affordable Coverage in Individual Health Insurance Markets
35. Chapter 2 - Premium Regulation, Risk Equalization, Risk Sharing, and Subsidies: Effects on Affordability and Efficiency
36. Can universal access be achieved in a voluntary private health insurance market? Dutch private insurers caught between competing logics
37. Cooperation amongst insurers on enhancing quality of care: precondition or substitute for competition?
38. Health effects of caring for and about parents and spouses
39. Informal caregiving, a healthy decision? Determinants and health-related consequences of providing informal care
40. Access to coverage for high-risks in a competitive individual health insurance market: via premium rate restrictions or risk-adjusted premium subsidies?
41. Towards a reinforced agency role of health insurers in Belgium and the Netherlands
42. Value-based provider payment: towards a theoretically preferred design.
43. Price effects of a hospital merger: Heterogeneity across health insurers, hospital products, and hospital locations.
44. Can universal access be achieved in a voluntary private health insurance market? Dutch private insurers caught between competing logics.
45. PREMIUM LEVELS AND DEMAND RESPONSE IN HEALTH INSURANCE: RELATIVE THINKING AND ZERO-PRICE EFFECTS.
46. Trends in ageing and ageing-in-place and the future market for institutional care: scenarios and policy implications.
47. The impact of geographic market definition on the stringency of hospital merger control in Germany and the Netherlands.
48. Effects of purchaser competition in the Dutch health system: is the glass half full or half empty?
49. Sustainability of Comprehensive Universal Long-term Care Insurance in the Netherlands.
50. Effects of purchaser competition in the Dutch health system: is the glass half full or half empty?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.